390 related articles for article (PubMed ID: 25492944)
1. SOD1 Function and Its Implications for Amyotrophic Lateral Sclerosis Pathology: New and Renascent Themes.
Bunton-Stasyshyn RK; Saccon RA; Fratta P; Fisher EM
Neuroscientist; 2015 Oct; 21(5):519-29. PubMed ID: 25492944
[TBL] [Abstract][Full Text] [Related]
2. Mutant SOD1 mediated pathogenesis of Amyotrophic Lateral Sclerosis.
Kaur SJ; McKeown SR; Rashid S
Gene; 2016 Feb; 577(2):109-18. PubMed ID: 26657039
[TBL] [Abstract][Full Text] [Related]
3. Extracellular wildtype and mutant SOD1 induces ER-Golgi pathology characteristic of amyotrophic lateral sclerosis in neuronal cells.
Sundaramoorthy V; Walker AK; Yerbury J; Soo KY; Farg MA; Hoang V; Zeineddine R; Spencer D; Atkin JD
Cell Mol Life Sci; 2013 Nov; 70(21):4181-95. PubMed ID: 23765103
[TBL] [Abstract][Full Text] [Related]
4. Delayed disease onset and extended survival in the SOD1G93A rat model of amyotrophic lateral sclerosis after suppression of mutant SOD1 in the motor cortex.
Thomsen GM; Gowing G; Latter J; Chen M; Vit JP; Staggenborg K; Avalos P; Alkaslasi M; Ferraiuolo L; Likhite S; Kaspar BK; Svendsen CN
J Neurosci; 2014 Nov; 34(47):15587-600. PubMed ID: 25411487
[TBL] [Abstract][Full Text] [Related]
5. Is SOD1 loss of function involved in amyotrophic lateral sclerosis?
Saccon RA; Bunton-Stasyshyn RK; Fisher EM; Fratta P
Brain; 2013 Aug; 136(Pt 8):2342-58. PubMed ID: 23687121
[TBL] [Abstract][Full Text] [Related]
6. SOD1 aggregation and ALS: role of metallation states and disulfide status.
Sheng Y; Chattopadhyay M; Whitelegge J; Valentine JS
Curr Top Med Chem; 2012; 12(22):2560-72. PubMed ID: 23339308
[TBL] [Abstract][Full Text] [Related]
7. Metal-deficient SOD1 in amyotrophic lateral sclerosis.
Hilton JB; White AR; Crouch PJ
J Mol Med (Berl); 2015 May; 93(5):481-7. PubMed ID: 25754173
[TBL] [Abstract][Full Text] [Related]
8. Canine degenerative myelopathy: biochemical characterization of superoxide dismutase 1 in the first naturally occurring non-human amyotrophic lateral sclerosis model.
Crisp MJ; Beckett J; Coates JR; Miller TM
Exp Neurol; 2013 Oct; 248():1-9. PubMed ID: 23707216
[TBL] [Abstract][Full Text] [Related]
9. Superoxide dismutase 1 mutants related to amyotrophic lateral sclerosis induce endoplasmic stress in neuro2a cells.
Oh YK; Shin KS; Yuan J; Kang SJ
J Neurochem; 2008 Feb; 104(4):993-1005. PubMed ID: 18233996
[TBL] [Abstract][Full Text] [Related]
10. Oxidized/misfolded superoxide dismutase-1: the cause of all amyotrophic lateral sclerosis?
Kabashi E; Valdmanis PN; Dion P; Rouleau GA
Ann Neurol; 2007 Dec; 62(6):553-9. PubMed ID: 18074357
[TBL] [Abstract][Full Text] [Related]
11. Zinc pre-treatment enhances NMDAR-mediated excitotoxicity in cultured cortical neurons from SOD1(G93A) mouse, a model of amyotrophic lateral sclerosis.
Nutini M; Frazzini V; Marini C; Spalloni A; Sensi SL; Longone P
Neuropharmacology; 2011 Jun; 60(7-8):1200-8. PubMed ID: 21056589
[TBL] [Abstract][Full Text] [Related]
12. Mutant SOD1 alters the motor neuronal transcriptome: implications for familial ALS.
Kirby J; Halligan E; Baptista MJ; Allen S; Heath PR; Holden H; Barber SC; Loynes CA; Wood-Allum CA; Lunec J; Shaw PJ
Brain; 2005 Jul; 128(Pt 7):1686-706. PubMed ID: 15872021
[TBL] [Abstract][Full Text] [Related]
13. New links between SOD1 and metabolic dysfunction from a yeast model of amyotrophic lateral sclerosis.
Bastow EL; Peswani AR; Tarrant DS; Pentland DR; Chen X; Morgan A; Staniforth GL; Tullet JM; Rowe ML; Howard MJ; Tuite MF; Gourlay CW
J Cell Sci; 2016 Nov; 129(21):4118-4129. PubMed ID: 27656112
[TBL] [Abstract][Full Text] [Related]
14. Silence superoxide dismutase 1 (SOD1): a promising therapeutic target for amyotrophic lateral sclerosis (ALS).
Abati E; Bresolin N; Comi G; Corti S
Expert Opin Ther Targets; 2020 Apr; 24(4):295-310. PubMed ID: 32125907
[No Abstract] [Full Text] [Related]
15. Amyotrophic lateral sclerosis models derived from human embryonic stem cells with different superoxide dismutase 1 mutations exhibit differential drug responses.
Isobe T; Tooi N; Nakatsuji N; Aiba K
Stem Cell Res; 2015 Nov; 15(3):459-468. PubMed ID: 26413785
[TBL] [Abstract][Full Text] [Related]
16. Protein misfolding in the late-onset neurodegenerative diseases: common themes and the unique case of amyotrophic lateral sclerosis.
Mulligan VK; Chakrabartty A
Proteins; 2013 Aug; 81(8):1285-303. PubMed ID: 23508986
[TBL] [Abstract][Full Text] [Related]
17. Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
Milanese M; Giribaldi F; Melone M; Bonifacino T; Musante I; Carminati E; Rossi PI; Vergani L; Voci A; Conti F; Puliti A; Bonanno G
Neurobiol Dis; 2014 Apr; 64():48-59. PubMed ID: 24361555
[TBL] [Abstract][Full Text] [Related]
18. Genotype-property patient-phenotype relations suggest that proteome exhaustion can cause amyotrophic lateral sclerosis.
Kepp KP
PLoS One; 2015; 10(3):e0118649. PubMed ID: 25798606
[TBL] [Abstract][Full Text] [Related]
19. Transgenic mouse model for familial amyotrophic lateral sclerosis with superoxide dismutase-1 mutation.
Shibata N
Neuropathology; 2001 Mar; 21(1):82-92. PubMed ID: 11304046
[TBL] [Abstract][Full Text] [Related]
20. A systematic immunoprecipitation approach reinforces the concept of common conformational alterations in amyotrophic lateral sclerosis-linked SOD1 mutants.
Fujisawa T; Yamaguchi N; Kadowaki H; Tsukamoto Y; Tsuburaya N; Tsubota A; Takahashi H; Naguro I; Takahashi Y; Goto J; Tsuji S; Nishitoh H; Homma K; Ichijo H
Neurobiol Dis; 2015 Oct; 82():478-486. PubMed ID: 26297318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
